ProALL Blood Test

ProALLBL blood predictive lab test is being clinically developed for frequent and long-term monitoring of acute lymphoblastic leuekemia patients. Findings reported at the 2016 58th ASH Conference in San Diego show that ProALLBL miRNA levels correlate with ProALLBM miRNA levels in bone marrow.  ProALLBL significantly predicted relapse of ALL patients.

Curewize is now performing the Clinical Trial "Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk" for the development of ProALLBL blood test.

ProALLBL Test Highlights

ProALL Blood Test for Leukemia